Anthem backs healthtech startup Vim

Israeli healthtech startup Vim  announced the completion of a $60 million series B funding round with investments from Walgreens Boots Alliance (WBA), Anthem, and Frist Cressey Ventures. The company raised $24 million in the first part of the round in 2019.

Founded in 2015, the company (a team of ~97) provides an online service that helps patients and healthcare providers find, schedule, and receive care from doctors and specialists. Vim’s solutions include: Quality Gaps, Diagnosis Gaps, Referral Guidance, and Digital Scheduling solutions that “easily and seamlessly” integrate with existing clinical systems at the point of care to reduce burden for health plans and providers.

“We believe data connected in clinical workflows is essential to drive real-time decision support at the point of care, and Vim’s approach allows us to deepen our integration capabilities across the clinical ecosystem. Supporting Vim’s work to connect health plan payers to providers is a valuable opportunity and we’re looking forward to seeing their technology continue to move health care forward.” – Jared Josleyn, Vice President of Innovation, Walgreens Boots Alliance.

“We are honored to be backed by and working in partnership with some of the largest and most innovative companies in US health care. We share a vision for powering a new era of network performance by seamlessly integrating data at the point of care to improve quality, experience, and total cost of care. These investments and partnerships represent major leaps forward for Vim and our opportunity to make an ever deeper and broader impact on US health care.” – Oron Afek, Vim Co-Founder and CEO.